Leaflet OXIMED 0.255mg / 0.085mg cutaneous spray, suspension


Indicated for: bacterial infections

Route of administration: cutaneous

Substance: oxytetracycline + hydrocortisone (tetracycline antibiotic + glucocorticoid)

ATC: D07CA01 (Dermatologicals | Corticosteroids, combinations with antibiotics | Corticosteroids, weak, combinations with antibiotics)

The combination of oxytetracycline and hydrocortisone is used in the treatment of bacterial skin infections accompanied by inflammation. Oxytetracycline is a broad-spectrum antibiotic that inhibits bacterial growth, while hydrocortisone is a corticosteroid that reduces inflammation and itching.

The medication is applied topically, as directed by a doctor, usually two to three times daily to the affected area. It is important for patients to follow the treatment duration to prevent recurrence of the infection.

Patients should be aware of potential side effects, such as local irritation, skin dryness, or allergic reactions. It is important to inform the doctor of any unusual symptoms.

Common side effects include local irritation and skin dryness. In rare cases, severe reactions such as hypersensitivity or secondary infections may occur. Patients should be informed of these risks before use.

General data about OXIMED 0.255mg / 0.085mg

  • Substance: oxytetracycline + hydrocortisone
  • Date of last drug list: 01-10-2014
  • Commercial code: W01888001
  • Concentration: 0.255mg / 0.085mg
  • Pharmaceutical form: cutaneous spray, suspension
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

  • Manufacturer: MEBRA SRL - ROMANIA
  • Holder: MEBRA SRL - ROMANIA
  • Number: 5285/2005/01
  • Shelf life: 2 years